Authorised Prescriber - Online Application Support Session
-
Overview
NOTE: This SAGED offering is specifically for doctors. Please review the following information and legal disclaimer before proceeding with your purchase.
Under TGA laws, there are four approved pathways for doctors to access unapproved medical cannabis products, provided it is clinically suitable for their patients:
- Authorised Prescriber - Established History of Use pathway
- Authorised Prescriber - Standard pathway
- SAS Category A notification pathway
- SAS Category B application pathway
This session is tailored to assist doctors in navigating the Authorised Prescriber - Established History of Use pathway (1.).
Guided by our prescriber support specialist via an online video meeting, you’ll receive step-by-step assistance in applying for a minimum of four (4) Authorised Prescriber (AP) approvals, equipping you to prescribe medical cannabis to patients with qualifying needs.
In this 1-hour session, you will have the option to apply for AP approvals for specific, clinically-supported conditions, including:
- Refractory chronic pain in adult patients
- Refractory anxiety in adult patients
- Refractory sleep disorders in adult patients
- Refractory cancer pain in adult patients
- Refractory autism spectrum disorder in adult patients
Estimated Duration: 1 hour
Delivery Format: Online video meeting
Session Outcomes
Upon completion of your online session:
- You will have successfully submitted applications for a minimum of four (up to ten) Authorised Prescriber (AP) approvals with the TGA.
- Receive the outcome of your TGA applications within approximately 10 business days after submission.
Please note: Approval is subject to TGA decision, and successful applications are not guaranteed.
- Once you receive your TGA outcome letters for approved applications, you can begin prescribing medical cannabis.*
*Within Australia, every medical cannabis prescription must be accompanied by the prescriber’s TGA outcome letter which enables the specific medical cannabis product to be ordered and dispensed by the relevant pharmacy.
Overview
NOTE: This SAGED offering is specifically for doctors. Please review the following information and legal disclaimer before proceeding with your purchase.
Under TGA laws, there are four approved pathways for doctors to access unapproved medical cannabis products, provided it is clinically suitable for their patients:
- Authorised Prescriber - Established History of Use pathway
- Authorised Prescriber - Standard pathway
- SAS Category A notification pathway
- SAS Category B application pathway
This session is tailored to assist doctors in navigating the Authorised Prescriber - Established History of Use pathway (1.).
Guided by our prescriber support specialist via an online video meeting, you’ll receive step-by-step assistance in applying for a minimum of four (4) Authorised Prescriber (AP) approvals, equipping you to prescribe medical cannabis to patients with qualifying needs.
In this 1-hour session, you will have the option to apply for AP approvals for specific, clinically-supported conditions, including:
- Refractory chronic pain in adult patients
- Refractory anxiety in adult patients
- Refractory sleep disorders in adult patients
- Refractory cancer pain in adult patients
- Refractory autism spectrum disorder in adult patients
Estimated Duration: 1 hour
Delivery Format: Online video meeting
Session Outcomes
Upon completion of your online session:
- You will have successfully submitted applications for a minimum of four (up to ten) Authorised Prescriber (AP) approvals with the TGA.
- Receive the outcome of your TGA applications within approximately 10 business days after submission.
Please note: Approval is subject to TGA decision, and successful applications are not guaranteed.
- Once you receive your TGA outcome letters for approved applications, you can begin prescribing medical cannabis.*
*Within Australia, every medical cannabis prescription must be accompanied by the prescriber’s TGA outcome letter which enables the specific medical cannabis product to be ordered and dispensed by the relevant pharmacy.